Celcius Logistics, third-party logistics and cold supply chain solutions provider, launched a specialised logistics arm for pharmaceutical supply chain, Celcius+.
“Our investment in this vertical marks the beginning of a focused journey to bridge gaps in pharma distribution with tech-backed, Goods Distribution Practice (GDP)-compliant solutions,’‘ Swarup Bose, Founder and CEO, Celcius Logistics, told newspersons here on Tuesday.
“This initiative is in line with Celcius Logistics’ mission to bridge cold chain gaps, reduce wastage and enable safe, timely deliveries for life-saving products. We’re confident that Celcius+ will help pharmaceutical companies extend their reach safely and efficiently across major cities by year-end.”
Designed to meet the sector’s stringent requirements for temperature control, compliance and real-time visibility, Celcius+ ensures medicines, vaccines and other sensitive products are transported with maximum safety and efficiency, he added.
In its initial phase, Celcius will invest ₹50 crore to create a dedicated pharma fleet and support infrastructure, with a goal of achieving ₹100 crore in Annual Recurring Revenue (ARR) from this segment within the next 18 months.
Fund use
Of this, ₹35 crore will be allocated towards deploying 100 new reefer vehicles for Celcius+ along key pharmaceutical corridors across India. A further ₹10-15 crore is being earmarked to build a robust pharma courier system tailored to serve high-demand urban and semi-urban markets, Bose said.
To support this rapid expansion, Celcius will add 30-40 specialised team members with expertise in pharma logistics, operations and regulatory compliance.
“With this new vertical, we plan to partner with leading pharmaceutical companies and extend its reach to more than 100 cities across India by the end of 2025,’‘ Bose added.
Celcius+ will deliver tech-enabled supply chain solutions tailored for pharmaceutical and healthcare clients, addressing critical challenges such as temperature-sensitive logistics, regulatory adherence and real-time shipment visibility.
The vertical will focus on high-value, sensitive segments including vaccines, biologics, insulin and specialty medicines, offering services that span primary distribution, secondary distribution and last-mile pharma courier delivery.
Earlier this year, Celcius Logistics raised ₹250 crore in an oversubscribed Series B funding round to accelerate technology upgrades and expand its network.
